中文版 | English

个人主页

关键词云

成果统计

合作作者[TOP 5]

  • 姜标

    合作成果数：21

  • 杨小宝

    合作成果数：18

  • 任超伟

    合作成果数：18

  • 陈金聚

    合作成果数：18

  • 赵全菊

    合作成果数：16

访问统计


  总访问量
 1114
  访问来源
    内部： 7
    外部： 1107
    国内： 879
    国外： 235

  年访问量
 167
  访问来源
    内部： 0
    外部： 167
    国内： 149
    国外： 18

  月访问量
 3
  访问来源
    内部： 0
    外部： 3
    国内： 2
    国外： 1

访问量

访问量

1. Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiti.. [3137]
2. 2-Bromopalmitate targets retinoic acid receptor alpha and overcome.. [1195]
3. Discovery and characterization of novel potent BCR-ABL degraders b.. [786]
4. Inhibition of mitochondrial complex III induces differentiation in.. [735]
5. PROTEIN DEGRADATION TARGETING COMPOUND, ANTI-TUMOR APPLICATION, .. [635]
6. PROTEIN DEGRADATION TARGETING COMPOUND, ANTI-TUMOR APPLICATION, .. [633]
7. Protein degradation targeting compound, anti-tumor application, .. [615]
8. Discovery of a Brigatinib Degrader SIAIS164018 with Destroying Met.. [578]
9. A DNA-encoded library for the identification of natural product bi.. [548]
10. Optimization of novel benzofuro[3,2-b]pyridin-2(1H)-one derivative.. [547]
11. Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase.. [546]
12. PROTEIN DEGRADATION TARGETING BCR-ABL COMPOUND AND ANTITUMOR APPLI.. [514]
13. 蛋白降解靶向化合物、其抗肿瘤应用、其中间体及中间体应用 [499]
14. COMPOUNDS TARGETING AND DEGRADING BCR-ABL PROTEIN AND ITS ANTITUMO.. [471]
15. TARGET PROTEIN DEGRADATION COMPOUNDS, THEIR ANTI-TUMOR USE, THEI.. [464]
16. Targeting Bcl-xL is a potential therapeutic strategy for extranoda.. [462]
17. 一种胺氟化莪术醇衍生化合物及及其应用与制备方法 [451]
18. TARGET PROTEIN DEGRADATION COMPOUNDS, THEIR ANTI-TUMOR USE, THEI.. [443]
19. Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase.. [419]
20. 靶蛋白降解化合物及其抗肿瘤用途，中间体和中间体 [372]
21. 三氟甲基那可丁衍生物及其制备方法与应用 [368]
22. 烷基取代那可丁衍生物及其制备方法与应用 [352]
23. Long non-coding RNA ARHGAP5-AS1 inhibits migration of breast cance.. [349]
24. 蛋白降解靶向化合物、其抗肿瘤应用、其中间体及中间体应用 [335]
25. Rapid monitoring of T- lymphocyte CD4+/CD8+ratio in patient immune.. [329]
26. Identification of acute myeloid leukemia by infrared difference sp.. [327]
27. The target proteolytic compounds, its anti-tumor applications, i.. [278]
28. 抗白血病硒代那可丁衍生物的制备方法及其应用 [258]
29. 硒代、硫代或氧代那可丁衍生物及其合成与在肿瘤治疗中的应用 [225]
30. PREPARATION METHOD FOR AND USE OF ANTI-LEUKEMIA SELENIUM-SUBSTITUT.. [224]
31. 蛋白降解靶向BCR-ABL化合物及其抗肿瘤应用 [224]
32. 靶蛋白降解化合物、其抗肿瘤用途、其中间体及其用途 [112]
33. Discovery of novel and highly potent anticancer agents enabled by .. [12]

下载量

1. Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiti.. [738]
2. 2-Bromopalmitate targets retinoic acid receptor alpha and overcome.. [329]
3. Discovery of a Brigatinib Degrader SIAIS164018 with Destroying Met.. [17]
4. Discovery and characterization of novel potent BCR-ABL degraders b.. [12]
5. A DNA-encoded library for the identification of natural product bi.. [7]
6. Identification of acute myeloid leukemia by infrared difference sp.. [7]
7. Targeting Bcl-xL is a potential therapeutic strategy for extranoda.. [7]
8. Rapid monitoring of T- lymphocyte CD4+/CD8+ratio in patient immune.. [6]
9. 硒代、硫代或氧代那可丁衍生物及其合成与在肿瘤治疗中的应用 [6]
10. Protein degradation targeting compound, anti-tumor application, .. [5]
11. Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase.. [5]
12. Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase.. [5]
13. 蛋白降解靶向化合物、其抗肿瘤应用、其中间体及中间体应用 [4]
14. The target proteolytic compounds, its anti-tumor applications, i.. [4]
15. 靶蛋白降解化合物及其抗肿瘤用途，中间体和中间体 [3]
16. Discovery of novel and highly potent anticancer agents enabled by .. [3]
17. TARGET PROTEIN DEGRADATION COMPOUNDS, THEIR ANTI-TUMOR USE, THEI.. [2]
18. Optimization of novel benzofuro[3,2-b]pyridin-2(1H)-one derivative.. [1]
19. PREPARATION METHOD FOR AND USE OF ANTI-LEUKEMIA SELENIUM-SUBSTITUT.. [1]
20. 烷基取代那可丁衍生物及其制备方法与应用 [1]
21. 一种胺氟化莪术醇衍生化合物及及其应用与制备方法 [1]
22. 蛋白降解靶向化合物、其抗肿瘤应用、其中间体及中间体应用 [1]